We know NIV works well for patients with acute COPD or acute CHF exacerbations. In this episode we discuss the evidence for NIV not only in COPD and CHF, but also a myriad of other conditions. Do you know what the latest guidelines say on NIV for asthma, immunocompromised patients, or undifferentiated acute respiratory failure? Take a listen!
You can get CME credit for this episode hereClick here for CME Account Creation Instructions
ED Pharmacist extraordinaire Jill Logan joins CCPEM to discuss the use of high-dose nitroglycerin in patients with acute cardiogenic pulmonary edema. Is it safe? ...
Peds EM superstars Mimi Lu and Barrie Bostick join CCPEM to review the latest clinical guidelines on hemodynamic support of pediatric and neonatal septic...
Over 80% of patients with sepsis receive care in the ED. Despite evidence demonstrating the benefits of ED sepsis resuscitation, there remains significant controversies...